Atracurium besylate
CAS: 64228-81-5
Ref. TM-T6397
10mg | 35,00 € | ||
25mg | 57,00 € | ||
50mg | 71,00 € | ||
100mg | 104,00 € | ||
200mg | 156,00 € | ||
500mg | 239,00 € | ||
1ml*10 (DMSO) | 59,00 € |
Información del producto
- Tracrium, 51W89, BW-33A
- 1-(3,4-dimethoxybenzyl)-2-(3-{[5-({3-[4-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-3,4-dihydroisoquinolinium-2(1H)-yl]propanoyl}oxy)pentyl]oxy}-3-oxopropyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium
- 2,2'-[1,5-Pentanediylbis[3-oxo-3,1-propanediyl]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrehydro-6,7-dimethoxy-2-methylisoquinolinium]dibenzenesulfonate
- 2,2'-[1,5-Pentanediylbis[Oxy(3-Oxo-3,1-Propanediyl)]]Bis[1-[(3,4-Dimethoxyphenyl)Methyl]-1,2,3,4-Tetrahydro-6,7-Dimethoxy-2-Methyl-Isoquinolinium Dibenzenesulfonate
- Atracurium Besilate
- Atracurium dibesilate
- Atracurium dibesylate
- Bw 33A
- Isoquinolinium, 2,2′-[1,5-pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, benzenesulfonate (1:2)
- Isoquinolinium, 2,2′-[1,5-pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, dibenzenesulfonate
- Ver más sinónimos
- Tracrium
- Tracur
- Wellcome 33A74
Atracurium besylate (51W89) is a non-depolarizing neuromuscular blocking agent with short duration of action. Its lack of significant cardiovascular effects and its lack of dependence on good kidney function for elimination provide clinical advantage over alternate non-depolarizing neuromuscular blocking agents.
Propiedades químicas
Consulta técnica sobre: TM-T6397 Atracurium besylate
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.